ARMCX2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.79118999819184E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.8070001878433E-10 |
Normal-vs-Stage2 |
8.68449978597141E-10 |
Normal-vs-Stage3 |
1.69408931327553E-12 |
Normal-vs-Stage4 |
1.32429622823338E-11 |
Stage1-vs-Stage2 |
5.371000E-01 |
Stage1-vs-Stage3 |
8.363300E-04 |
Stage1-vs-Stage4 |
1.337600E-01 |
Stage2-vs-Stage3 |
1.220370E-01 |
Stage2-vs-Stage4 |
5.158000E-01 |
Stage3-vs-Stage4 |
3.644200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.15272244474818E-12 |
Normal-vs-AfricanAmerican |
1.997600E-03 |
Normal-vs-Asian |
3.75780000000381E-05 |
Caucasian-vs-AfricanAmerican |
1.213990E-01 |
Caucasian-vs-Asian |
7.160200E-01 |
AfricanAmerican-vs-Asian |
3.315400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.97943916602617E-12 |
Normal-vs-Female |
1.7510437544388E-12 |
Male-vs-Female |
7.580800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.37320000004326E-06 |
Normal-vs-Age(41-60Yrs) |
2.49499976234802E-10 |
Normal-vs-Age(61-80Yrs) |
1.61426427780498E-12 |
Normal-vs-Age(81-100Yrs) |
7.97140131680862E-14 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.323800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.990800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.493800E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.422200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.195900E-04 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.802040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.609400E-01 |
Normal-vs-Grade 2 |
1.95049532081271E-11 |
Normal-vs-Grade 3 |
1.05604414102345E-12 |
Normal-vs-Grade 4 |
2.74410494327526E-11 |
Grade 1-vs-Grade 2 |
2.179000E-01 |
Grade 1-vs-Grade 3 |
1.776800E-01 |
Grade 1-vs-Grade 4 |
1.648600E-01 |
Grade 2-vs-Grade 3 |
9.329500E-02 |
Grade 2-vs-Grade 4 |
2.056400E-01 |
Grade 3-vs-Grade 4 |
7.010000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.29891669537119E-12 |
Normal-vs-ccB subtype |
7.00729474445438E-11 |
ccA subtype-vs-ccB subtype |
2.095800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.28288524037634E-12 |
Normal-vs-N1 |
3.29225535722344E-12 |
N0-vs-N1 |
1.195970E-02 |
|
|